Evidence map›Paper›PMID 32342503›Full record

ArticleBritish journal of haematology2020

LyRIC indeterminate response and Immune-mediated pseudoprogression of diffuse large B-cell lymphoma following polatuzumab-based salvage therapy.

Alexander T J Lee, Ayoma D Attygale, Rajaei K Sharma, Sunil Iyengar, Dima El-Sharkawi, Ian Chau, Katherine M Vroobel, Nicos Fotiadis, Nasir Khan, Nicholas Butterfield and 3 more

Abstract readLetterComment
PubMed Publisher
In one paragraph

Article in British journal of haematology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors.

Alexander T J LeeThe Royal Marsden NHS Foundation Trust, London, UK.ORCID 0000-0003-2976-6811
Ayoma D AttygaleThe Royal Marsden NHS Foundation Trust, London, UK.
Rajaei K SharmaThe University of Exeter Medical School, Exeter, UK.
Sunil IyengarThe Royal Marsden NHS Foundation Trust, London, UK.
Dima El-SharkawiThe Royal Marsden NHS Foundation Trust, London, UK.ORCID 0000-0002-2752-5814
Ian ChauThe Royal Marsden NHS Foundation Trust, London, UK.
Katherine M VroobelThe Royal Marsden NHS Foundation Trust, London, UK.
Nicos FotiadisThe Royal Marsden NHS Foundation Trust, London, UK.
Nasir KhanThe Royal Marsden NHS Foundation Trust, London, UK.
Nicholas ButterfieldThe Royal Marsden NHS Foundation Trust, London, UK.
Andrew WotherspoonThe Royal Marsden NHS Foundation Trust, London, UK.
David CunninghamThe Royal Marsden NHS Foundation Trust, London, UK.
Bhupinder SharmaThe Royal Marsden NHS Foundation Trust, London, UK.

Funding

National Institute of Health Research
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

ImmunoconjugatesLymphoma, Large B-Cell, DiffuseAntibodies, MonoclonalHumansSalvage TherapyAntibodies, MonoclonalImmunoconjugatespolatuzumab vedotindiffuse large B cell lymphomapolatuzumabpseudo-progression

Identifiers

PMID32342503

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.